[Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3]

Minerva Med. 1985 Mar 10;76(9-10):407-14.
[Article in Italian]
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Alkaline Phosphatase / blood
  • Calcium / blood
  • Cholecalciferol / therapeutic use
  • Chronic Kidney Disease-Mineral and Bone Disorder / diagnostic imaging
  • Chronic Kidney Disease-Mineral and Bone Disorder / drug therapy
  • Chronic Kidney Disease-Mineral and Bone Disorder / etiology*
  • Female
  • Humans
  • Hyperparathyroidism, Secondary / blood
  • Hyperparathyroidism, Secondary / drug therapy
  • Hyperparathyroidism, Secondary / etiology*
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / therapy*
  • Long-Term Care
  • Male
  • Middle Aged
  • Osteomalacia / diagnostic imaging
  • Osteomalacia / drug therapy
  • Osteomalacia / etiology
  • Parathyroid Glands / surgery
  • Parathyroid Hormone / blood
  • Phosphorus / blood
  • Radiography
  • Receptors, Calcitriol
  • Receptors, Steroid / therapeutic use*
  • Renal Dialysis / adverse effects*

Substances

  • Parathyroid Hormone
  • Receptors, Calcitriol
  • Receptors, Steroid
  • Cholecalciferol
  • Phosphorus
  • Alkaline Phosphatase
  • Calcium